Pfizer Inc.

NYSE: PFE · Real-Time Price · USD
25.16
0.05 (0.20%)
At close: Aug 15, 2025, 3:59 PM
25.14
-0.06%
After-hours: Aug 15, 2025, 07:58 PM EDT

Pfizer Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 29, 2025 Mar 29, 2025 Dec 31, 2024 Sep 29, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Oct 1, 2023 Jul 2, 2023 Apr 2, 2023 Dec 31, 2022 Oct 2, 2022 Jul 3, 2022 Apr 3, 2022 Dec 31, 2021 Oct 3, 2021 Jul 4, 2021 Apr 4, 2021
Net Income
10.79B 7.9B 8.05B 4.3B -2.58B -281M 2.13B 10.48B 21.52B 29.06B 31.39B 30.24B 29.77B 25.46B 22.46B 16.58B 10.62B 8.49B
Depreciation & Amortization
6.79B 6.89B 7.01B 6.89B 6.7B 6.54B 6.29B 6.14B 5.76B 5.36B 5.06B 4.82B 5B 5.15B 5.19B 4.96B 4.86B 4.79B
Stock-Based Compensation
824M 827M 877M 821M 698M 640M 525M 768M 752M 891M 872M 1B 1.16B 1.09B 1.18B 950M 881M 847M
Other Working Capital
3.81B -1.65B -3.07B 2.46B 380M -1M -2.17B -9.52B -12.43B -11.28B -6.5B -1.92B 8.95B 17.1B 16.5B 15.26B 7.64B 1.61B
Other Non-Cash Items
-5.21B 2.34B 1.97B 360M 6B 4.96B 5.37B 4.08B -1.31B -101M 155M 136M -1.93B -3.72B -4.77B 744M 2.66B 3.07B
Deferred Income Tax
-1.81B -2.32B -2.1B -3.56B -3.19B -3.29B -3.44B -1.95B -1.77B -2.04B -3.76B -3.99B -7.8B -6.81B -4.29B -4.57B -1.49B -1.38B
Change in Working Capital
3.81B -1.65B -3.07B 2.46B 380M -1M -2.17B -7.47B -10.38B -9.23B -4.46B -5.62B 5.26B 13.41B 12.81B 13.63B 6.01B -21M
Operating Cash Flow
15.19B 13.99B 12.74B 11.26B 8.01B 8.58B 8.7B 12.04B 14.56B 23.94B 29.27B 26.6B 31.45B 34.58B 32.58B 32.29B 23.55B 15.81B
Capital Expenditures
-2.75B -2.77B -2.91B -3.04B -3.19B -3.47B -3.91B -3.86B -3.9B -3.73B -3.24B -3.23B -3.01B -2.8B -2.71B -3B -2.91B -2.85B
Cash Acquisitions
3.55B 9.86B 7.04B -39.91B -39.92B -39.94B -43.43B -16.8B -16.8B -16.77B -23B -6.24B -6.24B -6.24B -12M -583M -588M -589M
Purchase of Investments
-17.79B -15.1B -10.31B -4.91B -11.44B -26.48B -31.18B -26.88B -36.46B -39.47B -42.19B -58.93B -57.85B -49.97B -47.61B -28.36B -13.73B -18.49B
Sales Maturities Of Investments
20.23B 11.91B 8.83B 41.13B 50.43B 36.19B 46.42B 22.03B 26.63B 43.18B 48.87B 50.62B 44.01B 39.26B 28.1B 20.11B 15.47B 15.04B
Other Investing Acitivies
308M 298M n/a 3M 347M -158M -177M -183M 3.32B 3.76B 3.77B 3.82B -324M -482M -306M 212M 688M 940M
Investing Cash Flow
3.54B 4.19B 2.65B -6.72B -3.78B -33.86B -32.28B -25.69B -27.21B -13.04B -15.78B -13.96B -23.41B -20.23B -22.55B -11.63B -1.07B -5.95B
Debt Repayment
-8.13B -7.42B -7.16B 3.34B 4.16B 33.8B 35.95B 25.39B 23.3B -1.72B -3.52B -2.1B 2.18B -2.91B -1.1B -23.21B -24.62B -12.83B
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -2B -2B -2B -2B n/a n/a n/a n/a
Dividend Paid
-9.64B -9.58B -9.51B -9.45B -9.38B -9.32B -9.25B -9.18B -9.11B -9.04B -8.98B -8.93B -8.87B -8.81B -8.73B -8.65B -8.58B -8.51B
Other Financial Acitivies
-397M -439M -469M -473M -504M -582M -632M -607M -565M -271M -335M -141M 179M 126M 16M 11.62B 11.23B 11.08B
Financial Cash Flow
-18.17B -17.44B -17.14B -6.58B -5.73B 23.91B 26.07B 15.61B 13.63B -11.03B -14.83B -13.17B -8.51B -13.59B -9.82B -20.25B -21.97B -10.26B
Net Cash Flow
582M 712M -1.8B -2.05B -1.55B -1.42B 2.47B 1.89B 870M -296M -1.52B -668M -566M 733M 187M 408M 574M -386M
Free Cash Flow
12.44B 11.22B 9.84B 8.23B 4.81B 5.11B 4.79B 8.18B 10.66B 20.21B 26.03B 23.37B 28.44B 31.78B 29.87B 29.29B 20.64B 12.96B